Results showed a significant upregulation of the activity of CSNK2A1, CDK1, PLK1, PRKDC, and CDK2 in HCC (Fig. 4I and supplemental Table S3). This evidence concerns the gene CSNK2A1 and hepatocellular carcinoma.